As 2023 comes to an end, we celebrate the work achieved by our team and our collaborating institutions in advancing maternal and perinatal health. We close the year having surpassed 5200 citations on our combined INTERGROWTH-21st standards papers.

Highlights include the publication of the first normative digital fetal brain atlas in Nature, laying the ground for a better understanding of fetal development. This work was conducted with the Department of Computer Science, the Wellcome Centre for Integrative Neuroimaging, the Department of Engineering Science, the Big Data Institute, and the Department of Psychiatry.

In the same collaborative spirit, with the WHO, we proudly contributed to the publication of the new standards and findings on the association between maternal hemoglobin concentrations and maternal and neonatal outcomes in The Lancet Haematology.

We have launched a new INTERPRACTICE body composition study, with sites in Argentina, Uruguay, and the United Kingdom. We also commenced a NIHR-funded study, in collaboration with the University of Southampton, examining the feasibility of the INTER-NDA for the developmental screening of NICU graduates.

We welcomed the initiative led by The Lancet and the BJOG to introduce the new Small Vulnerable Newborns unifying concept and the use by the large and diverse consortium of scientists, practitioners, and policymakers that developed this framework. We are also proud to have joined the Women in Science program to curtail gender-based leadership biases in the low- and middle-income countries of South and Central Asia and East Africa.

None of this work would have been possible without all our little patients, their mothers and families, our collaborators, the health authorities of participating institutions and countries, and our funders, the Bill and Melinda Gates Foundation, the Family Larsson-Rosenquist Foundation, the NIHR, and the Waterloo Foundation. We extend to them our most heartfelt gratitude.

The Oxford Maternal and Perinatal Health Institute